Half-year report · Q2

Period2024-10-01 → 2025-03-31
Filed2025-05-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥24.1bn2024-10-01 → 2025-03-31Cons.Net sales
Revenue¥46.1bn2023-10-01 → 2024-09-30Cons.Net sales (5-year summary)
Revenue¥21.4bn2023-10-01 → 2024-03-31Cons.Net sales
Operating income¥2.3bn2024-10-01 → 2025-03-31Cons.Operating income
Operating income¥1.4bn2023-10-01 → 2024-03-31Cons.Operating income
Ordinary income¥2.2bn2024-10-01 → 2025-03-31Cons.Ordinary income
Ordinary income¥4.4bn2023-10-01 → 2024-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.2bn2023-10-01 → 2024-03-31Cons.Ordinary income
Profit before tax¥1.8bn2024-10-01 → 2025-03-31Cons.Income before income taxes
Profit before tax¥6.0bn2023-10-01 → 2024-03-31Cons.Income before income taxes
Net income (owners)¥1.3bn2024-10-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.1bn2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.3bn2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income¥1.3bn2024-10-01 → 2025-03-31Cons.Profit loss
Net income¥4.3bn2023-10-01 → 2024-03-31Cons.Profit loss
Total assets¥92.7bnat 2025-03-31Cons.Assets
Total assets¥90.0bnat 2024-09-30Cons.Assets
Total assets¥85.0bnat 2024-03-31Cons.Total assets (5-year summary)
Total liabilities¥46.9bnat 2025-03-31Cons.Liabilities
Total liabilities¥44.4bnat 2024-09-30Cons.Liabilities
Net assets / equity¥45.7bnat 2025-03-31Cons.Net assets
Net assets / equity¥45.6bnat 2024-09-30Cons.Net assets
Net assets / equity¥44.1bnat 2024-03-31Cons.Net assets (5-year summary)
Cash and deposits¥6.7bnat 2025-03-31Cons.Cash and deposits
Cash and deposits¥4.6bnat 2024-09-30Cons.Cash and deposits
Cash & equivalents¥6.7bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥4.6bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.4bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2023-09-30dCons.Cash and cash equivalents
Operating cash flow¥2.1bn2024-10-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥4.2bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥445m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.8bn2024-10-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2023-10-01 → 2024-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.5bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥2.8bn2024-10-01 → 2025-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥435m2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.0bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥52.832024-10-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥252.852023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥175.152023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.3%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.6%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio51.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 493
ItemContextValueUnit
Proceeds from long term loans payable fin cfPrior1YTDDuration-JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration9000000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-3810000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-6300000000JPY
Proceeds from issuance of bonds fin cfPrior1YTDDuration-JPY
Proceeds from issuance of bonds fin cfCurrentYTDDuration986000000JPY
Redemption of bonds fin cfPrior1YTDDuration-300000000JPY
Redemption of bonds fin cfCurrentYTDDuration-300000000JPY
Cash dividends paid fin cfPrior1YTDDuration-432000000JPY
Cash dividends paid fin cfCurrentYTDDuration-547000000JPY
Repayments of lease obligations fin cfPrior1YTDDuration-287000000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-260000000JPY
Proceeds from sale and leaseback fin cfPrior1YTDDuration2331000000JPY
Proceeds from sale and leaseback fin cfCurrentYTDDuration-JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration-JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration171000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-1998000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration2750000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration37000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration-7000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-948000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration2109000000JPY
Cash and cash equivalentsPrior2YearInstant2324000000JPY
Cash and cash equivalentsPrior1YearInstant4585000000JPY
Cash and cash equivalentsPrior1QuarterInstant1375000000JPY
Cash and cash equivalentsCurrentQuarterInstant6695000000JPY
Salaries and bonuses sgaPrior1YTDDuration1629000000JPY
Salaries and bonuses sgaCurrentYTDDuration1845000000JPY
Research and development expenses sgaPrior1YTDDuration1726000000JPY
Research and development expenses sgaCurrentYTDDuration1363000000JPY
Provision for bonuses sgaPrior1YTDDuration246000000JPY
Provision for bonuses sgaCurrentYTDDuration388000000JPY
Retirement benefit expenses sgaPrior1YTDDuration73000000JPY
Retirement benefit expenses sgaCurrentYTDDuration106000000JPY
Provision for directors bonuses sgaPrior1YTDDuration5000000JPY
Provision for directors bonuses sgaCurrentYTDDuration7000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の5第1項の表の第1号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-05-09
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第61期中(自 2024年10月1日 至 2025年3月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)富士製薬工業株式会社
Company name in english cover pageFilingDateInstantFuji Pharma Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長  森田 周平
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区三番町5番地7
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(3556)3344(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員 経営管理部長  宇治 浩
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区三番町5番地7
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(3556)3344(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員 経営管理部長  宇治 浩

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-09-30pass
balance sheet identityconsolidated 2025-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-10-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2024-10-01/2025-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2024-10-01/2025-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass